|
|
|
|
| TRADING CENTER |
42.29+0.20 / +0.48%
GlaxoSmithKline PLC (NYSE:GSK)
Prev. Close:
42.09
Open:
42.05
High:
42.36
Low:
42.03
Volume:
276,090
Volume Avg.:
1,607,100
52wk Range:
27.15 - 43.47
Market Cap (mil):
109,729.76
P/E Ratio:
12.97
Dividend Yield:
N/A
| Another Reason to Worry About Pfizer - MotleyFool.com | |
| Pfizer's Prevnar Gains Acceptance - Analyst Blog - Zacks.com | |
| 2009 Cheers and Jeers for Pharma - MotleyFool.com | |
| Pfizer Swings for the Fences - MotleyFool.com | |
| 2009 Biotech Cheers and Jeers - MotleyFool.com | |
| Amgen Closer to Prolia Approval - Analyst Blog - Zacks.com | |
| New Japanese flu drug protects mice from avian flu - Reuters | |
| Better Buy: Pfizer or GlaxoSmithKline? - MotleyFool.com | |
| Now Is the Time to Buy Risk - MotleyFool.com | |
| Swine Flu Just Isn't Bringing Home the Bacon - MotleyFool.com | |
| 3 Reasons to Sell Dendreon Today - MotleyFool.com | |
| Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immun... - Business Wire | |
| Zacks Industry Outlook Highlights: UnitedHealth Group Inc., Cigna Corp., Pfizer Inc.,... - Zacks.com | |
| EU Panel Backs DuoCover From Bristol-Myers Squibb Pharma - Dow Jones | |
| Drugmakers Win With Democrats' Help - at TheStreet.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.70 | 0.13 / 0.20% | 14.13 |
| PFE | Pfizer Inc | 18.60 | 0.02 / 0.11% | 15.63 |
| NVS | Novartis AG | 54.84 | 0.24 / 0.44% | 15.40 |
Short Interest Date:
Nov 30 2009
Short Interest Shares:
4,972,311
Short Interest Ratio:
2.9
Float:
n/a
Short Interest as a % of Float:
n/a
Average Daily Volume:
1,882,200
Outstanding Shares:
2,830,658,118
GlaxoSmithKline plc is a public limited company, which was incorporated on 6th December 1999 under English law. It is a global healthcare Group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products including vaccines, over-the-counter ... (more)
| 2008 Revenue: | $35.0 B | Headquarters: Brentford, Middlesex, |
| Employees: | 99,003 | CEO: Andrew Witty |
| Net Income: | $6.8 B | Industry: Pharmaceuticals |
| Market Cap: | $119.1 B | Website: www.gsk.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| GSK | 42.29 | +0.20 / +0.48% | 42.09 | 42.36 | 42.03 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
